Gagnon Securities LLC Has $3.21 Million Holdings in Aspen Aerogels, Inc. $ASPN

Gagnon Securities LLC lessened its stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 35.4% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,133,248 shares of the construction company’s stock after selling 621,585 shares during the period. Gagnon Securities LLC owned 1.37% of Aspen Aerogels worth $3,207,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the stock. Vanguard Group Inc. lifted its position in shares of Aspen Aerogels by 0.5% during the 3rd quarter. Vanguard Group Inc. now owns 4,510,370 shares of the construction company’s stock valued at $31,392,000 after acquiring an additional 22,686 shares during the period. Geode Capital Management LLC lifted its position in shares of Aspen Aerogels by 1.1% during the 4th quarter. Geode Capital Management LLC now owns 1,602,049 shares of the construction company’s stock valued at $4,535,000 after acquiring an additional 17,178 shares during the period. JPMorgan Chase & Co. lifted its position in shares of Aspen Aerogels by 9.9% during the 4th quarter. JPMorgan Chase & Co. now owns 1,483,745 shares of the construction company’s stock valued at $4,199,000 after acquiring an additional 133,996 shares during the period. Millennium Management LLC lifted its position in shares of Aspen Aerogels by 59.6% during the 3rd quarter. Millennium Management LLC now owns 1,447,517 shares of the construction company’s stock valued at $10,075,000 after acquiring an additional 540,772 shares during the period. Finally, Goldman Sachs Group Inc. lifted its position in shares of Aspen Aerogels by 89.7% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company’s stock valued at $8,143,000 after acquiring an additional 602,586 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on ASPN. Roth Mkm reiterated a “buy” rating and set a $5.75 target price on shares of Aspen Aerogels in a research report on Friday, May 8th. Barclays boosted their target price on shares of Aspen Aerogels from $3.00 to $4.00 and gave the company an “underweight” rating in a research report on Monday, May 11th. TD Cowen dropped their target price on shares of Aspen Aerogels from $7.00 to $6.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Weiss Ratings restated a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Friday, March 27th. Finally, Wall Street Zen upgraded shares of Aspen Aerogels from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Three equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, Aspen Aerogels currently has a consensus rating of “Hold” and an average price target of $5.19.

Aspen Aerogels Stock Performance

Shares of ASPN stock opened at $5.91 on Friday. The firm has a 50-day moving average of $4.72 and a 200-day moving average of $3.80. The company has a market cap of $489.41 million, a P/E ratio of -4.34 and a beta of 3.03. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.89 and a quick ratio of 2.54. Aspen Aerogels, Inc. has a one year low of $2.30 and a one year high of $9.78.

Aspen Aerogels (NYSE:ASPN) last announced its earnings results on Thursday, May 7th. The construction company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.01). The firm had revenue of $37.88 million during the quarter, compared to analysts’ expectations of $36.58 million. Aspen Aerogels had a negative net margin of 48.64% and a negative return on equity of 22.16%. The business’s revenue for the quarter was down 51.8% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.06) EPS. Aspen Aerogels has set its Q2 2026 guidance at -0.240–0.17 EPS. Equities research analysts forecast that Aspen Aerogels, Inc. will post -0.8 EPS for the current fiscal year.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.